TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of

Daniel H Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.